<DOC>
	<DOCNO>NCT02593435</DOCNO>
	<brief_summary>Purpose : 1 . Screening large sample search gene mutation breast cancer susceptibility gene ( BRCA1 BRCA2 ) Chinese high risk group . 2 . To build breast cancer BRCA1/2 mutation database Chinese group . 3 . To build hazard model breast cancer BRCA1/2 mutation Chinese group .</brief_summary>
	<brief_title>The Registration Program BRCA1/2 Gene</brief_title>
	<detailed_description>It first large-scale systematic study fully recognize review mutation spectrum BRCA1/2 risk Breast cancer Chinese high risk group , Landmark research susceptibility gene Chinese breast cancer .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Chinese Genetic/Familial breast cancer patient , first second degree relative breast cancer ( female male ) . The selection base NCCN Clinical Practice Guidelines Oncology ( Genetic/Familial HighRisk Assessment : Breast Ovarian ) . Patients : must independent family meet one follow condition . 1 . Patients ' age diagnosis : 45 year younger . 2 . Patients ' age diagnosis : 50 year younger . 3 . Breast cancer patient : must meet one follow family medical history . 3.1 Patients ' age diagnosis : 50 year young , one next Kin breast cancer . 3.2 Patients ' age diagnosis : age , one next Kin breast cancer age diagnosis 50 year younger . 3.3 Patients ' age diagnosis : age , two next Kin breast cancer age diagnosis 50 year younger . 3.4 Patients ' age diagnosis : age , one next Kin epithelial ovarian cancer . 3.5 Patients ' age diagnosis : age , two next Kin pancreatic cancer and/or prostate cancer ( Gleason gradingï¼ž7 , age ) . 3.6 Patients ' age diagnosis : age , one closemale relatives breast cancer . 4 . Triple negative patient ' age onset : 60 year younger . 5 . Patients : male breast cancer . Patients ' first second degree relative BRCA1/2 mutation carrier ( 15 people ) : First second degree female adult relatives patient ( age : 18 year old ) , select paternal maternal side accord family disease . First second degree male relatives patient breast cancer .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>BRCA1/2 gene mutation</keyword>
	<keyword>Breast Cancer</keyword>
	<keyword>Chinese high risk group</keyword>
</DOC>